Baylor Miraca Genetics Laboratories LLC
Houston, TX Part of Baylor College Of Medicine
- UEI
- HV15NRPPNU25
- CAGE
- 7QCL7
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Corporate family
-
-
Parent
Houston, TX
FXKMA43NTV21
-
Parent
Houston, TX
FXKMA43NTV21
- SAM.gov registration date
- Physical address
- 2450 Holcombe Blvd #104, Houston, TX 77021, USA
- Website
- baylorgenetics.com
- Founded
- 1978
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $11,632,922 |
| FY2025 | $12,422,670 |
| FY2024 | $1,930,352 |
| FY2023 | $206,325 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $10,749,702 | |
| 2 | Department of Health and Human Services | $833,000 | |
| 3 | Defense Health Agency | $50,220 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Germline PGX molecular testing | year 3 | VA Strategic Acquisition Center Frederick | $11,387,675 | |
| Germline PGX molecular testing - year 2 | VA Strategic Acquisition Center Frederick | $11,387,675 | |
| Clinical testing | National Heart Lung and Blood Institute (NIH) | $231,600 | |
| Whole exome sequencing lab testing service | Defense Health Agency | $76,615 | |
| Germline PGX molecular testing | VA Strategic Acquisition Center Frederick | $344,429 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Infinity Biologix LLC D.b.a. Sampled | Piscataway, NJ | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Broad Clinical Laboratories, LLC | Cambridge, MA | 621511 Medical Laboratories |
| Fulgent Genetics, Inc. | El Monte, CA | 621511 Medical Laboratories |
| Natera Inc. | Austin, TX | 621511 Medical Laboratories |
| Invitae Corporation | — | 621511 Medical Laboratories |
About the company
Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, is a for-profit limited liability company subsidiary of Baylor College of Medicine that provides clinical genetic testing and molecular sequencing services to federal agencies as a prime contractor (100% of recent awards). Baylor Genetics operates in the Reference Laboratory Testing PSC category under NAICS 621511 (Medical Laboratories) and competes full-and-open without set-aside designations across its federal footprint.
The vendor's federal customer base concentrates sharply on the Department of Veterans Affairs, which accounts for approximately 93% of combined potential value across just four awards. The VA Strategic Acquisition Center Frederick awarded Baylor Genetics a $99 million multiple-award IDIQ for germline pharmacogenomics molecular testing services running through September 29, 2029, with firm fixed-price delivery orders issued under it; the most recent Year 3 delivery order carries a $11.4 million ceiling with completion by September 29, 2027, and a prior Year 2 delivery order was valued at $11.4 million. The second-largest customer is the National Institute of Allergy and Infectious Diseases (NIAID), which has placed 14 awards totaling approximately $8 million for microarray testing, whole genome sequencing, and clinical testing services; a representative example is a $7.1 million firm fixed-price purchase order awarded September 25, 2024, for whole genome sequencing (1,400 whole genomes with raw data delivery and 250 with data, interpretation, and clinical report) with performance in Houston, Texas and completion by September 24, 2028. The National Human Genome Research Institute has awarded four purchase orders totaling $489 thousand for whole genome sequencing and clinical testing to support the Undiagnosed Disease Program, and the Defense Health Agency awarded a $227 thousand purchase order on October 1, 2024, for whole exome sequencing lab testing services through September 30, 2029, performed in San Diego, California.
Baylor Genetics holds one parent vehicle — the Germline PGx Services IDIQ from VA Strategic Acquisition Center Frederick — which accounts for three task orders carrying $23.1 million in combined potential value. The vendor operates exclusively as a prime contractor with no subcontractor relationships; SCI-reported invoicing totaled $2 million in FY2025 across 2.0 FTEs with no recorded subcontracted hours. Activity has been irregular: four awards in 2022, four in 2023, six in 2024, two in 2025, and one in 2026 (the most recent VA delivery order issued September 30, 2026). Two awards with combined potential value $18.5 million face ultimate completion inside the next twenty-four months, presenting recompete opportunity. Baylor Genetics is a subsidiary of Baylor College of Medicine and performs testing work at facilities in Houston, Texas and Frederick, Maryland, with capability spanning whole genome sequencing, microarray testing (including SNP and comparative genomic hybridization microarray analysis), whole exome sequencing, and pharmacogenomics molecular analysis to support VA clinical practice and NIH research missions.
Quick answers
Is Baylor Miraca Genetics Laboratories LLC registered in SAM.gov?
Yes. Baylor Miraca Genetics Laboratories LLC's SAM.gov registration is active through August 13, 2027.
Which contract vehicles does Baylor Miraca Genetics Laboratories LLC hold?
Baylor Miraca Genetics Laboratories LLC holds a place on 1 federal contract vehicle: Germline PGx Services.
How much has Baylor Miraca Genetics Laboratories LLC received in federal contracts?
Federal contracts obligated $12,422,670 to Baylor Miraca Genetics Laboratories LLC in fiscal year 2025 and $26,192,269 in fiscal years 2023 through 2027.
How does Baylor Miraca Genetics Laboratories LLC rank among federal contractors?
Baylor Miraca Genetics Laboratories LLC ranked #5 in PSC Q3, #6 in NAICS 621511 and #8 in NAICS 6215 in FY2025.
What is Baylor Miraca Genetics Laboratories LLC's most recent federal award?
Baylor Miraca Genetics Laboratories LLC's most recent federal contract award is Germline PGX molecular testing | year 3 (36C10X26N0164), from VA Strategic Acquisition Center Frederick, on September 30, 2026.
On GovTribe
See Baylor Miraca Genetics Laboratories LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors